Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

8.5K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.5K
Mitochondria01:37

Mitochondria

17.6K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
17.6K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

3.2K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
3.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

16.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
16.8K
Mitochondrial Membranes01:45

Mitochondrial Membranes

14.9K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
14.9K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

15.9K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Patient Preferences in Neuromuscular Diseases: Insights for Future Drug Development.

JIMD reports·2026
Same author

Adjunctive transcranial DC stimulation in the management of refractory drug-resistant focal epilepsy in POLG mitochondrial disease: A case series.

Seizure·2026
Same author

Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial.

Scientific reports·2026
Same author

Quantifying variability of mitochondrial markers in m3243A > G myopathy.

Scientific reports·2025
Same author

Elevated glioma-related cortical glutamate <i>in vivo</i> is associated with <i>ex vivo</i> interictal discharges in human brain slices.

Brain communications·2025
Same author

Model systems informing mechanisms and drug discovery: a review of <i>POLG</i>-related disease models.

Wellcome open research·2025

関連する実験動画

Updated: Nov 14, 2025

Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

4.5K

ミトコンドリア 疾患: 将来 の 希望

Oliver M Russell1, Gráinne S Gorman2, Robert N Lightowlers3

  • 1Wellcome Centre for Mitochondrial Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK; Clinical and Translational Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Cell
|March 30, 2020
PubMed
まとめ

ミトコンドリア疾患は 遺伝子の変異に起因します 現在の治療法では 症状が治りますが 小分子療法や遺伝子療法や ゲルムライン介入などの 新しい治療法は 根本的な欠陥を修正することを目的としています

さらに関連する動画

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

4.1K
Generation of Human Brain Organoids for Mitochondrial Disease Modeling
08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.5K

関連する実験動画

Last Updated: Nov 14, 2025

Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

4.5K
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
06:05

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model

Published on: March 9, 2022

4.1K
Generation of Human Brain Organoids for Mitochondrial Disease Modeling
08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.5K

科学分野:

  • 遺伝学
  • 生物化学
  • 分子生物学

背景:

  • ミトコンドリア疾患は 多様な遺伝疾患のグループです
  • 現在の治療は 主に症状を緩和するだけで 根本的な原因を 解決しないのです

研究 の 目的:

  • ミトコンドリア疾患の治療における最近の進歩をレビューする.
  • 新しい治療戦略と予防策を探求する

主な方法:

  • 小分子療法に関する文献レビュー
  • 遺伝子療法のアプローチの分析
  • ゲルムラインの伝播防止技術の検討

主要な成果:

  • 新興の小分子薬は 特定の欠陥をターゲットにすると有望です
  • 核とミトコンドリアのDNA変異に対して 遺伝子治療が進んでいます
  • ゲルムラインの介入は 病気の遺伝を防ぐ可能性を秘めています

結論:

  • ミトコンドリア疾患の標的治療の開発には大きな進展が見られます.
  • これらの疾患の管理には 治療戦略と予防方法の組み合わせが不可欠です